Skin Cancer: Clinical Trials

266 trials for Skin Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

135 completed, 47 recruiting, 26 unknown, 20 terminated. 102 Not applicable, 48 Phase 2, 24 Phase 1, 10 Phase 3, 8 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable102Completed 54, Recruiting 21, Unknown 11, Terminated 5, Withdrawn 5, Active not recruiting 4, Not yet recruiting 2
Phase 248Completed 23, Terminated 11, Recruiting 7, Active not recruiting 3, Withdrawn 3, Unknown 1
Phase 124Completed 10, Recruiting 6, Active not recruiting 3, Unknown 3, Terminated 2
Phase 310Completed 7, Active not recruiting 2, Not yet recruiting 1
Early Phase 18Completed 3, Recruiting 3, Active not recruiting 1, Unknown 1
Phase 45Recruiting 2, Completed 1, Not yet recruiting 1, Terminated 1

Follow Skin Cancer: new trials by email Literature Review of Skin Cancer trials Research Report on Skin Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery
Suzetrigine, Acetaminophen Plus Ibuprofen - Postoperative Pain, Acute Pain
Phase 4Not yet recruitingUniversity of Minnesota2302027-04-012026-09-25
E-MOHS Trial of TENS and Vibration During Local Anesthesia
Active Vibration:TENS, Sham TENS - Pain, Procedural Pain
Not applicableNot yet recruitingUniversity of Minnesota902027-01-012026-10-06
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
iSCIB1+, Nivolumab & Ipilimumab, Placebo - Melanoma (Skin Cancer), Advanced Melanoma
Phase 3Not yet recruitingScancell Ltd5502026-12-012026-09-11
Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision
Cyanoacrylate Skin Adhesive, Fast Gut Running Epidermal Suture Closure, Vicryl Rapide Running Epidermal Suture Closure - Surgical Site Infection, Skin Cancer
Not applicableNot yet recruitingUniversity of Minnesota3002026-10-262026-10-20
Mobile Sun Health Intervention EnabLing Daily Protection
Text Message Reminders, Sun Protection Education Modules, Action Planning Module - Skin Cancer
Not applicableRecruitingUniversity of Utah202026-07-132026-09-24
Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program
Skin Cancer Self-Detection Educational Program with gain-framing, Skin Cancer Self-Detection Educational Program with loss-framing, Wait-list Control - Skin Cancer, Skin Cancer Prevention
Not applicableRecruitingNational University Hospital, Singapore2802026-06-152026-09-24
CARES : Customized Aftercare Report for Evaluated Skin Cancer Patients
Verbal information only, Personalized Discharge Letter, Personalized Discharge Letter + IntelliStudio - Management, Low Risk
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven1502026-05-202026-05-22
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
Topical niacinamide 5% cream, Sunscreen - Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC)
Early Phase 1RecruitingMarissa Lobl202026-05-012026-06-05
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Cosibelimab, Prednisone, Sirolimus - Cutaneous Squamous Cell Carcinoma, Skin Cancer
Phase 4RecruitingDana-Farber Cancer Institute802026-04-232026-08-11
TIL Therapy in cSCC and MCC
LN-145, Cyclophosphamide, Fludarabine - Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma
Phase 2RecruitingKaram Khaddour, MD, MS142026-02-102026-02-13
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Intervention with telemedicine tool - Skin Cancer Prevention, Melanoma In Situ
Not applicableRecruitingInstitute of Health Information and Statistics of the Czech Republic14402026-02-012026-03-27
Validation of Clinical Biomarkers Using Spatial Transcriptomics and Development of a Diagnostic Test to Characterize the Progression Potential of Cutaneous Precancerous Lesions
Skin Cancer, Diagnostic
Active not recruitingCentre Hospitalier Régional Metz-Thionville1402026-02-012026-06-03
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Immunotherapy, Cutaneous Squamous Cell Carcinoma
Phase 2WithdrawnMassachusetts General Hospital2026-01-012025-05-07
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
DaRT seeds - Squamous Cell Carcinoma, Alpha Radiation
Not applicableRecruitingAlpha Tau Medical LTD.282026-01-012026-07-15
Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Cutaneous Squamous Cell Carcinoma, Actinic Keratoses
Phase 2WithdrawnMassachusetts General Hospital2026-01-012025-05-07
The Florida ASCENT Study
MyCarePulse and ASCENT PN - Cancer, Food Deprivation
Not applicableRecruitingUniversity of Florida1002025-12-052026-07-23
Preoperative Image-based Education Effect on Postoperative Satisfaction of Patients Undergoing First-time Dermatologic Surgery
Preoperative image-based education - Skin Cancer, Skin Wound
Not applicableWithdrawnJohns Hopkins University2025-12-012024-04-08
Cancer Prevention & Online Technologies
Prevention video advertisement, Prevention images for advertisement, No Advertisement - Skin Cancer
Not applicableWithdrawnStanford University2025-12-012026-04-20
Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.
Skin Cancer, Diagnostic
RecruitingCentre Hospitalier Régional Metz-Thionville1402025-12-012026-06-24
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
A novel hGIIA-Vimentin Inhibitor, Dose expansion - Prostate Cancers, Breast Cancer
Phase 1 / Phase 2RecruitingFilamon LTD802025-11-072026-03-17

Showing 20 of 266. Sign in to see all of them.

Narrower conditions

Skin Neoplasms (266)  ·  Melanoma (90)  ·  Carcinoma, Basal Cell (37)  ·  Carcinoma, Squamous Cell (35)  ·  Breast Neoplasms (22)  ·  Lung Neoplasms (21)  ·  Head and Neck Neoplasms (18)  ·  Neoplasms (18)  ·  Urinary Bladder Neoplasms (14)  ·  Kidney Neoplasms (13)  ·  Squamous Cell Carcinoma of Head and Neck (13)  ·  Colorectal Neoplasms (12)  ·  Pancreatic Neoplasms (12)  ·  Prostatic Neoplasms (12)  ·  Esophageal Neoplasms (11)

Broader conditions

Neoplasms by Site (266)  ·  Skin and Connective Tissue Diseases (266)  ·  Skin Diseases (259)  ·  Neoplasms (248)  ·  Neoplasms by Histologic Type (135)  ·  Neoplasms, Germ Cell and Embryonal (97)  ·  Neoplasms, Nerve Tissue (97)  ·  Neuroectodermal Tumors (97)  ·  Neuroendocrine Tumors (92)  ·  Nevi and Melanomas (92)  ·  Neoplasms, Glandular and Epithelial (65)  ·  Carcinoma (57)  ·  Pathological Conditions, Signs and Symptoms (38)  ·  Neoplasms, Basal Cell (36)  ·  Neoplasms, Squamous Cell (33)

Interventions

Cyclophosphamide (14)  ·  aldesleukin (14)  ·  Nivolumab (11)  ·  fludarabine (11)  ·  fludarabine phosphate (11)  ·  Interleukin-2 (10)  ·  Ipilimumab (7)  ·  Surveys and Questionnaires (6)  ·  pembrolizumab (5)  ·  Radiotherapy (4)  ·  Sirolimus (4)  ·  Biopsy (3)  ·  Blood Specimen Collection (3)  ·  Cisplatin (3)  ·  Fluorouracil (3)

Sponsors

National Cancer Institute (NCI) (15)  ·  M.D. Anderson Cancer Center (9)  ·  Alpha Tau Medical LTD. (8)  ·  H. Lee Moffitt Cancer Center and Research Institute (8)  ·  Klein Buendel, Inc. (8)  ·  Memorial Sloan Kettering Cancer Center (7)  ·  Massachusetts General Hospital (6)  ·  Maastricht University Medical Center (5)  ·  University of Utah (5)  ·  Dana-Farber Cancer Institute (4)  ·  Herlev Hospital (4)  ·  University of California, Davis (4)  ·  Barco NV (3)  ·  Centre Hospitalier Universitaire de Saint Etienne (3)  ·  Institute of Oncology Ljubljana (3)

Countries

United States (161)  ·  France (15)  ·  United Kingdom (13)  ·  Australia (11)  ·  Denmark (10)  ·  Sweden (8)  ·  Switzerland (7)  ·  Belgium (6)  ·  Germany (6)  ·  Israel (6)  ·  Netherlands (6)  ·  Italy (5)  ·  Spain (5)  ·  Canada (3)  ·  Slovenia (3)

Top investigators

Steven A Rosenberg, M.D. (8)  ·  David Buller, PhD (4)  ·  K Mosterd, MD, PhD (4)  ·  April W Armstrong, MD (2)  ·  Bonnie S. Glisson, MD, BS (2)  ·  David Polsky, MD, PhD (2)  ·  Gustav G Nervil, MD (2)  ·  Jason Reichenberg, MD (2)  ·  Josep Malvehy, MD (2)  ·  Karam Khaddour, MD (2)  ·  Lesley E Rhodes, MBBS, MD (2)  ·  Mary Buller, MA (2)  ·  Paul Chapman, MD (2)  ·  Shadmehr Demehri, MD/PHD (2)

Results publications

PMID 23861247, PMID 10602908, PMID 15061852, PMID 15753371, PMID 16478735, PMID 19196482, PMID 19430405, PMID 19686304, PMID 19917951, PMID 20210522, PMID 20855696, PMID 21238825, PMID 21757257, PMID 21943390, PMID 22025453, PMID 22056381, PMID 22099239, PMID 22555974, PMID 22830463, PMID 22864522, PMID 22932225, PMID 22992358, PMID 23351338, PMID 23364005, PMID 24311515, PMID 24493717, PMID 24857018, PMID 25306116, PMID 25432172, PMID 25695689, PMID 26178731, PMID 26202595, PMID 26454512, PMID 27459457, PMID 27899339, PMID 29048958, PMID 29149611, PMID 29445030, PMID 29511007, PMID 29537906, PMID 29698824, PMID 30016177, PMID 32374352, PMID 32942054, PMID 33064988, PMID 33089943, PMID 33294862, PMID 33429351, PMID 34359770, PMID 34713152

NIH funding

2023 (2), R44CA221591 (2), R44CA257778 (2), 1DP2CA225433-01 (1), 2008 (1), 2017 (1), 2018 (1), 5UC2CA148310-02 (1), KL2TR002374-07 (1), N01CN35158 (1), P30CA016672 (1), P50CA121974 (1), R01CA074592 (1), R01CA134705 (1), R01CA187191 (1)